(MENAFN- The Express Wire) Posted on Oct 14 2021 9:00 AM
"Cancer Cachexia Market Worth USD 2.93 Billion at 4.8% CAGR; High Efficiency of Progestogens to Surge Growth: Fortune Business Insights™"
The global cancer cachexia market is anticipated to gain traction from the rising shift of the healthcare providers towards combination therapies. Such therapies are aiding in improving the lean body mass (LBM) of patients. This information is given by Fortune Business Insights™ in a recently published report, titled,“Cancer Cachexia Market Size, Share & Covid-19 Impact Analysis, By Product (Progestogens, Corticosteroids, Combination Therapies, and Others), By Distributional Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The report further states that this market size was USD 2.02 billion in 2019 and is projected to reach USD 2.93 billion by 2027, thereby exhibiting a CAGR of 4.8% during the forecast period.
The emergence of the COVID-19 pandemic has brought the entire world to a standstill. The governments of several countries have implemented lockdown measures to prevent the spread of this deadly infection. Such initiatives have caused disruptions in the production and supply chain. But, with time and perseverance, we will be able to battle this severe phase and come back to normalcy. Our authentic reports would help you to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.
“Get Sample PDF of report, please connect with our sales team below.“
Name: Mr. Ashwin Arora
Email: sales [@] fortunebusinessinsights [.] com
Phone: US +1424 253 0390 / UK +44 2071 939123
How Will the Outbreak of COVID-19 Affect the Global Market?
- Patients living with chronic diseases, such as cancer cachexia are at high risk of catching the coronavirus infection.
- It is likely to occur as these patients tend to suffer from multiple comorbidities.
- In Italy, a retrospective analysis was conducted by taking 355 patients under consideration who expired because of COVID-19. Out of those, 20.0% patients were suffering from cancer.
- These factors are propelling numerous medical associations to implement stringent guidelines for the healthcare workers and cancer patients.
- They are advising to utilize telehealth for receiving supportive care and treatment.
Major Cancer Cachexia manufacturers are studied in this report for better understanding of global market scenario:
- Bristol-Myers Squibb Company, New York, U.S.
- ANI Pharmaceuticals, Inc., Baudette, U.S.
- Merck & Co., Inc., Kenilworth, U.S.
- Hikma Pharmaceuticals PLC, London, U.K.
- Mylan N.V., Pennsylvania, U.S.
- AbbVie, Inc., North Chicago, U.S.
- Pfizer Inc., New York, U.S.
- Teva Pharmaceutical Industries Ltd., Petach-Tikva, Israel
North America to Lead Backed by Presence of Favorable Reimbursement Policies
Geographically, in 2019, North America procured USD 0.80 billion in terms of revenue. The region is likely to lead the market throughout the forecast period. This growth is attributable to the increasing awareness programs amongst the masses about the benefits of supportive care for cancer. Apart from this, the presence of favorable reimbursement policies in the developed countries, such as Canada and the U.S. would contribute to the growth of the market in this region. Europe is expected to exhibit a considerable CAGR in the coming years owing to the high demand for therapeutics for the treatment of cancer cachexia . Asia Pacific, on the other hand, is set to grow significantly fueled by the increasing investments by the prominent companies present in the region in research and development activities.
The global pandemic, COVID-19, has led to severe repercussion owing to its widespread effects across several economies. Several industries are facing unprecedented losses owing to the lockdown announced by several governments across the globe that has resulted in the complete shutdown of the businesses. The crippling economy, however, is being revived through collective efforts from the government as well as the industries and is expected to bounce back in the coming years.
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Cancer Cachexia Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.
“Have Any Query? Ask Our Expert:“
Name: Mr. Ashwin Arora
Email: sales [@] fortunebusinessinsights [.] com
Phone: US +1424 253 0390 / UK +44 2071 939123
Cancer Cachexia Highlights of the Report:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market. Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market Table of Content:
Introduction 1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptionss
Executive Summary Market Dynamics 3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
Key Insights 4.1. Prevalence of Cancer Cachexia, for Key Regions/ Country, 2019
4.2. Pipeline Analysis, By Key Players
4.3. Overview of Economic Cost Burden of Cancer & Supportive Care, for Key Regions/ Country
4.4 Key industry Developments – Mergers, Acquisition, Etc.
Global Cancer Cachexia Market Analysis, Insights and Forecast, 2016-2027 5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product
5.2.1 Progestogens
5.2.2 Corticosteroids
5.2.3 Combination Therapies
5.2.4 Others
5.3. Market Analysis, Insights and Forecast – By Distribution Channel
5.3.1 Hospital Pharmacy
5.3.2 Retail Pharmacy
5.3.3 Online Pharmacy
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1 North America
5.4.2 Europe
5.4.3 Asia pacific
5.4.4 Latin America
5.4.5 Middle East & Africa
North America Cancer Cachexia Market Analysis, Insights and Forecast, 2016-2027 6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Product
6.2.1 Progestogens
6.2.2 Corticosteroids
6.2.3 Combination Therapies
6.2.4 Others
6.3. Market Analysis, Insights and Forecast – By Distribution Channel
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.3.3 Online Pharmacy
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1 U.S.
6.4.2 Canada
Contact Us:
Name: Mr. Ashwin Arora
Email: sales [@] fortunebusinessinsights [.] com
Phone: US +1424 253 0390 / UK +44 2071 939123
MENAFN14102021004576010663ID1102970163
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.